Pfizer weighing sale of Hospira's pump business: Bloomberg
Drugmaker Pfizer Inc (PFE.N) is thinking about selling hospital products maker Hospira's infusion pump business for about $2 billion, Bloomberg reported, citing people familiar with the matter.





